JW Therapeutics competitorsClear all

Neovii's top competitors include Foghorn Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Neovii
Neovii
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date
Founding Date
2003
Founding Date
2016
Type
Type
Private
Type
Public
Tags
Locations
Locations
Rapperswil-Jona, CH HQ
Gräfelfing, DE
Lexington, US
Locations
Cambridge, US HQ
Cambridge, US
Employees
Employees
89
Employees
85
For sources of this data, please see the company profile

View company profiles

Foghorn Therapeutics
HQ
Cambridge, US
Employees
85

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company